Clinical Trial Update: Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial results from Phase 2 and Phase 3 studies examined using omega-3 fatty acids as an adjunct treatment for Major Depressive Disorder, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Cincinnati | Conditions: Major Depressive Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-12-04